SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001654954-21-001459
Filing Date
2021-02-10
Accepted
2021-02-10 21:11:28
Documents
5
Effectiveness Date
2021-02-10

Document Format Files

Seq Description Document Type Size
1 S-1MEF gtbp_s1mef.htm S-1MEF 98311
2 OPINION OF BAKER & MCKENZIE LLP gtbp_ex51.htm EX-5.1 18581
3 CONSENT OF SELIGSON & GIANNATTASIO, LLP gtbp_ex231.htm EX-23.1 4404
4 IMAGE gtbp_ex51000.jpg GRAPHIC 3984
5 IMAGE sidebar.jpg GRAPHIC 11303
  Complete submission text file 0001654954-21-001459.txt   143977
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-252973 | Film No.: 21616292
SIC: 2834 Pharmaceutical Preparations